arrow
L

Laura Visa

IIBB-CSIC
H指数:24
被引数:2,271

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune checkpoint inhibitor-related myocarditis, myositis, and myasthenia gravis overlap syndrome: a single-center case series and systematic review

免疫检查点抑制剂相关心肌炎、肌炎和重症肌无力重叠综合征:单中心病例系列和系统综述

2026-10-150
PRE
Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain

西班牙晚期食管胃腺癌患者PD-L1表达的实际情况分析

2026-04-280
OAAI
Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort

胃食管腺癌中Claudin 18.2的表达: 生物标志物重叠及其与欧洲队列临床结果的关联

2026-01-270
OAAI
Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis

围术期FLOT疗法是否能提高可切除食管腺癌的治愈率?——混合治愈模型分析

2025-11-260
OAAI
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry
2023-11-151
PRE
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

Agamenon-seom模型预测接受基于曲妥珠单抗的一线治疗的晚期HER2-positive食管胃腺癌患者的生存

2023-03-041
OAAI
Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
2022-06-010
OAAI
Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial
2022-01-1059
OAAI
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

可溶性AXL是早期检测胰腺导管腺癌和慢性胰腺炎鉴别诊断疾病的新型血液标志物

2022-01-0129
OAAI
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
2021-06-176
OAAI
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry
2021-03-028
OA
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
2020-09-248
OAAI
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer
2019-08-2822
PREAI